Five Patients Sought to Receive Donor Transplants of iPS Cells (News)

Science Technology

Kobe, Feb. 6 (Jiji Press)—The Riken Center for Developmental Biology and others said Monday that they have started soliciting five patients who want to join clinical research for transplants of retina cells created from induced pluripotent stem, or iPS, cells made from another person's cells.

A team led by Takahashi Masayo of the CDB plans to carry out a transplant for the first patient in the first half of this year.

Last week, Japan's health ministry approved the team's plan to carry out what will be the world's first clinical research on transplants to patients of iPS cells made from others.

At a press conference on Monday, the team said that using such iPS cells, made in advance for transplant surgery, will reduce the time and cost of such operations compared with making iPS cells from scratch using patients' own cells.

The team is seeking patients between 50 and 85 years old who are suffering from age-related macular degeneration, a serious eye disease that can lead to blindness.

[Copyright The Jiji Press, Ltd.]

Jiji Press medicine biology